The objective of this study is to evaluate the efficacy of FST-201 compared to Ciprodex in the treatment of acute otitis externa. This trial is designed to enable filing of a New Drug Application in support of FST-201 for the indication of acute otitis externa.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
5
Instill four drops two times a day
Instill four drops two times a day
ENT Associates of South Florida
Boynton Beach, Florida, United States
Unnamed facility
Sarasota, Florida, United States
Austin Ear, Nose, and Throat Clinic
Austin, Texas, United States
San Antonio Ear, Nose, and Throat Research
San Antonio, Texas, United States
Overall clinical cure as defined by absence of the signs and symptoms of AOE including ear inflammation, edema, tenderness and otic discharge.
Time frame: 1 year
Microbiological resolution defined as elimination of pre-treatment pathogenic bacteria.
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
San Antonio Ear, Nose, and Throat Research
San Antonio, Texas, United States
Ear Institute of Texas
San Antonio, Texas, United States